Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ZED-1227 by Zedira for Celiac Disease: Likelihood of Approval
ZED-1227 is under clinical development by Zedira and currently in Phase II for Celiac Disease. According to GlobalData, Phase II...